Antonio Stigliano

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Mild autonomous cortisol secretion and brain function: cognitive, structural, and functional correlates.

Mild autonomous cortisol secretion and brain function: cognitive, structural, and functional correlates.

Journal: Frontiers in endocrinology

Published: June 18, 2026

Real-World Effectiveness and Safety of Osilodrostat in Cushing's Syndrome: A Retrospective Phase IV Study.

Real-World Effectiveness and Safety of Osilodrostat in Cushing's Syndrome: A Retrospective Phase IV Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: January 01, 2026

Addison's disease in Italy: mortality and survival by etiology.

Addison's disease in Italy: mortality and survival by etiology.

Journal: Journal of endocrinological investigation

Published: December 22, 2025

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

Journal: The lancet. Diabetes & endocrinology

Published: November 09, 2025

Management of cushing's syndrome in patients with adrenocortical cancer: state of the art and future perspectives.

Management of cushing's syndrome in patients with adrenocortical cancer: state of the art and future perspectives.

Journal: Reviews in endocrine & metabolic disorders

Published: July 22, 2025

Morpho-Functional and Biochemical Characterization of Adrenal Masses in a Heterogeneous Cancer Population.

Morpho-Functional and Biochemical Characterization of Adrenal Masses in a Heterogeneous Cancer Population.

Journal: Cancers

Published: June 17, 2025

Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study.

Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study.

Journal: The lancet. Diabetes & endocrinology

Published: June 11, 2025

Extraordinary Response to Mitotane Monotherapy in Advanced Aggressive Adrenocortical Carcinoma.

Extraordinary Response to Mitotane Monotherapy in Advanced Aggressive Adrenocortical Carcinoma.

Journal: JCEM case reports

Published: March 24, 2025

The Combination of Afternoon and Midnight Salivary Cortisol Improves the Diagnosis of Cushing Syndrome.

The Combination of Afternoon and Midnight Salivary Cortisol Improves the Diagnosis of Cushing Syndrome.

Journal: The American journal of medicine

Published: December 27, 2024

Relacorilant or surgery improved hemostatic markers in Cushing syndrome.

Relacorilant or surgery improved hemostatic markers in Cushing syndrome.

Journal: Journal of endocrinological investigation

Published: April 19, 2024

SARS-CoV-2 Affects Thyroid and Adrenal Glands: An 18F-FDG PET/CT Study.

SARS-CoV-2 Affects Thyroid and Adrenal Glands: An 18F-FDG PET/CT Study.

Journal: Biomedicines

Published: September 26, 2023

Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT Interval.

Relacorilant, a Selective Glucocorticoid Receptor Modulator in Development for the Treatment of Patients With Cushing Syndrome, Does Not Cause Prolongation of the Cardiac QT Interval.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: August 14, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026